Acutus Medical Inc
AFIB
AFIB was delisted on the 8th of May, 2024.
65 hedge funds and large institutions have $22.3M invested in Acutus Medical Inc in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 21 closing their positions.
8% less funds holding
Funds holding: 71 → 65 (-6)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
46% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 26
63% less capital invested
Capital invested by funds: $60.6M → $22.3M (-$38.4M)
64% less call options, than puts
Call options by funds: $107K | Put options by funds: $296K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$846K |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$768K |
| 3 |
Renaissance Technologies
New York
|
+$767K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$584K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.84M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$743K |
| 3 |
Millennium Management
New York
|
-$609K |
| 4 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$520K |
| 5 |
Morgan Stanley
New York
|
-$490K |
AFIB Hedge Fund Activity: Q1 2022 in Review
65 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q1 2022, worth a combined $22.3M — down 63% from $60.6M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of AFIB and 15 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 14 added.
The largest buyer was GSA Capital Partners, adding an estimated $846K. The largest seller was Goldman Sachs, cutting an estimated $2.84M.
- 65 institutional investors held Acutus Medical Inc (AFIB) as of Q1 2022, down from 71 in Q4 2021.
- Funds reported $22.3M of Acutus Medical Inc stock for Q1 2022, down 63% quarter-over-quarter.
- 15 funds opened new Acutus Medical Inc positions in Q1 2022 and 21 closed out, a net change of -6 holders.
- The largest Acutus Medical Inc buyer in Q1 2022 was GSA Capital Partners, an estimated $846K added.
- The largest Acutus Medical Inc seller in Q1 2022 was Goldman Sachs, an estimated $2.84M sold.
Based on aggregated 13F filings for Q1 2022.